Comparison of Amfresh gel and Chlorhexidine gel as an adjunct to scaling and root planing in periodontitis patients.
Phase 2
- Conditions
- Health Condition 1: K053- Chronic periodontitisHealth Condition 2: Z515- Encounter for palliative care
- Registration Number
- CTRI/2021/11/038043
- Lead Sponsor
- Dr Swapna Mahale
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patient diagnosed with Generalised periodontitis stage 2 grade 2 currently unstable with no risk factor
2. Patients with persistent pocket depth of minimum 4 -6 mm having minimum of 2-3 sites.
3. Systemically healthy subjects.
Exclusion Criteria
1. History of any previous periodontal therapy in the last 6 months.
2.Use of drugs such as antibiotics, anti-inflammatory, corticosteroids, chemotherapeutics or immunological modulators that might alter the expected response of the oral tissues.
3. Tobacco consumption in any form.
4. Systemic diseases influencing the periodontal disease.
5. Pregnant and lactating women.
6. Allergy to chlorhexidine and Resveratrol, Chitosan, Neem & Curcumin (Amfresh) gel
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Plaque index (PI) (Silness J, Lo¨e H. 1964) <br/ ><br>Probing Pocket Depth (PPD) <br/ ><br>Relative Attachment Level (RAL)Timepoint: Baseline, 1 month and 3 months.
- Secondary Outcome Measures
Name Time Method Gingival Index (GI) (Loe and Silness, 1963) <br/ ><br>Sulcus Bleeding Index.(SBI)(Muhlemann H.R & Son,1971)Timepoint: Baseline, 1 month and 3 months.